Literature DB >> 25172521

Should we listen to our clock to prevent type 2 diabetes mellitus?

Ramanujam Karthikeyan1, Ganapathy Marimuthu2, David Warren Spence3, Seithikurippu R Pandi-Perumal4, Ahmed S BaHammam5, Gregory M Brown6, Daniel P Cardinali7.   

Abstract

The circadian clock drives a number of metabolic processes including energy intake, storage and utilization coupled with the sleep/wake cycles. Globally, the increasing prevalence of type 2 diabetes (T2DM) has become a significant international public health concern. In view of the heavy societal burden caused by diabetes, and further, to reduce its growing incidence, it is clearly essential to understand the causes of this disease and to devise more effective strategies for its treatment. Although many factors cause T2DM, this article centers on the role of circadian regulation of metabolism. The correlation between the increased occurrence of T2DM and the ubiquity of modern social pressures such as 24/7 lifestyles as well as nocturnal lighting conditions point strongly to the hypothesis that malfunctioning of circadian controls may be involved in the etiology of the illness. Nocturnal light exposure, unusual timing of food, irregular sleep/wake schedules and traveling between different time zones are some of the factors responsible for improper entrainment of the clock. Recent reports have proposed that strengthening of circadian clock functioning and proper timing of food intake could stabilize glucose homeostasis. This strategy thus represents a chronotherapeutic option for non-pharmaceutical intervention in treating T2DM patients.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Circadian rhythms; Clock genes; Melatonin.; Metabolism; Type 2 diabetes mellitus

Mesh:

Year:  2014        PMID: 25172521     DOI: 10.1016/j.diabres.2014.07.029

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

Review 1.  Chronomedicine and type 2 diabetes: shining some light on melatonin.

Authors:  Andrew C Forrestel; Susanne U Miedlich; Michael Yurcheshen; Steven D Wittlin; Michael T Sellix
Journal:  Diabetologia       Date:  2016-12-16       Impact factor: 10.122

Review 2.  Melatonin, mitochondria, and the metabolic syndrome.

Authors:  Daniel P Cardinali; Daniel E Vigo
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

3.  Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?

Authors:  Ramanujam Karthikeyan; David Warren Spence; Gregory M Brown; Seithikurippu R Pandi-Perumal
Journal:  J Circadian Rhythms       Date:  2018-04-18

4.  Chemical Constituents from Roots of Sophora davidii (Franch.) Skeels and Their Glucose Transporter 4 Translocation Activities.

Authors:  Kangdi Li; Yuanren Ma; Tongxi Zhou; Xinzhou Yang; Ho-Young Choi
Journal:  Molecules       Date:  2021-02-01       Impact factor: 4.411

5.  Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats.

Authors:  Mohammed H Elkomy; Hussein M Eid; Mohammed Elmowafy; Khaled Shalaby; Ameeduzzafar Zafar; Mohamed A Abdelgawad; Mostafa E Rateb; Mohammed R A Ali; Izzeddin Alsalahat; Heba A Abou-Taleb
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 6.  Evidences of Polymorphism Associated with Circadian System and Risk of Pathologies: A Review of the Literature.

Authors:  F J Valenzuela; J Vera; C Venegas; S Muñoz; S Oyarce; K Muñoz; C Lagunas
Journal:  Int J Endocrinol       Date:  2016-05-22       Impact factor: 3.257

Review 7.  Co-Morbidity, Mortality, Quality of Life and the Healthcare/Welfare/Social Costs of Disordered Sleep: A Rapid Review.

Authors:  Sergio Garbarino; Paola Lanteri; Paolo Durando; Nicola Magnavita; Walter G Sannita
Journal:  Int J Environ Res Public Health       Date:  2016-08-18       Impact factor: 3.390

8.  Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.

Authors:  Juntao Yin; Yantao Hou; Yuyun Yin; Xiaoyong Song
Journal:  Int J Nanomedicine       Date:  2017-12-06

Review 9.  The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Authors:  Eduardo Spinedi; Daniel P Cardinali
Journal:  Int J Endocrinol       Date:  2018-07-25       Impact factor: 3.257

10.  The contribution of modern 24-hour society to the development of type 2 diabetes mellitus: the role of insufficient sleep.

Authors:  Ramanujam Karthikeyan; David Warren Spence; Seithikurippu R Pandi-Perumal
Journal:  Sleep Sci       Date:  2019 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.